Trial Profile
A Phase IIb randomized, double-blinded, placebo-controlled, multicentre clinical trial of adult patients with systemic lupus erythematosus
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Aug 2016
Price :
$35
*
At a glance
- Drugs Anifrolumab (Primary)
- Indications Systemic lupus erythematosus
- Focus Biomarker; Therapeutic Use
- 08 Feb 2016 New trial record